Advanced Solid Tumors That Are MTAP Deficient
1 clinical trials · Condition
◉ Watch Advanced Solid Tumors That Are MTAP Deficient
| Record | Firm | Date |
|---|---|---|
| A Study of AZD3470, a PRMT5 Inhibitor, Given as Monotherapy and in Combination in Patients With MTAP Deficient Advanced/Metastatic Solid Tumors (NCT06130553) | AstraZeneca | 2024-01-18 |
Track Advanced Solid Tumors That Are MTAP Deficient automatically
Every clearance here is in the API, with alerts when new ones post.